Bio-Works Technologies AB (publ)

SSE:BIOWKS.ST

4.85 (SEK) • At close February 20, 2024
Bedrijfsnaam Bio-Works Technologies AB (publ)
Symbool BIOWKS.ST
Munteenheid SEK
Prijs 4.85
Beurswaarde 189,052,030
Dividendpercentage 0%
52-weken bereik 4.7 - 23.5
Industrie Biotechnology
Sector Healthcare
CEO Mr. Jonathan Royce
Website https://www.bio-works.com

An error occurred while fetching data.

Over Bio-Works Technologies AB (publ)

Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; BabyBio columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; OptioBio glass columns; screening kits; and size exclusion chromatography

Vergelijkbare Aandelen

InDex Pharmaceuticals Holding AB (publ) logo

InDex Pharmaceuticals Holding AB (publ)

INDEX.ST

0.244 SEK

Oncopeptides AB (publ) logo

Oncopeptides AB (publ)

ONCO.ST

7.264 SEK

FluoGuide A/S logo

FluoGuide A/S

FLUO.ST

55.6 SEK

Stille AB logo

Stille AB

STIL.ST

160.5 SEK

Episurf Medical AB (publ) logo

Episurf Medical AB (publ)

EPIS-B.ST

0.98 SEK

Mendus AB (publ) logo

Mendus AB (publ)

IMMU.ST

0.469 SEK

Egetis Therapeutics AB (publ) logo

Egetis Therapeutics AB (publ)

EGTX.ST

6.07 SEK

Enzymatica AB (publ) logo

Enzymatica AB (publ)

ENZY.ST

3.05 SEK

Financiële Gegevens

Cijfers zijn in miljoenen (SEK)

Cijfers zijn in miljoenen (SEK)